🚀Enjoy a 7-Day Free Trial Until Jul 20, 2024!

KU

Kuros Biosciences AGSWX Kuros Stock Report

Price

Market cap $B

Exchange

XSWX - Six Swiss Exchange

FAIR VALUE

Is KURN undervalued compared to its fair value?

The fair value of KURN stock is hidden CHF. Relative to the market price of 12.24 CHF Kuros Biosciences AG is hidden.

Kuros Biosciences Ltd. develops spinal fusion biologics that ease the burden of back pain. The company is headquartered in Schlieren, Zuerich. The company went IPO on 2002-10-29. Immunodrugs are therapeutic vaccines inte...[More about valuation]

Kuros Biosciences AG Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0.507 $B

Price:

12.24 CHF

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.319

FINANCIALS

Kuros Biosciences AG financial for reporting period

Income Statement

0.0076 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.011 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.011 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

0.0076 B 100%
0.0022 B 29%
-0.011 B -146%
-0.011 B -144%

Balance Sheet

0.083 B
0.069 B

0.0019 B

Financial Position Analysis

Assets

0.083 B
Current Assets
0.031 B
Total non-current assets
0.052 B

Total current liabilities
0.013 B
Total non-current liabilities
0.0015 B

Cash Flow Statement

-0.001 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0005 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Kuros Biosciences AG fundamental analysis for trailing twelve months (TTM)

Profitability score


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators

-21 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-24 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-17 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is KURN attractive for investment based on fundamental analysis?

KURN stock rating is hidden. Kuros Biosciences AG is a hidden by Eyestock methodology.

Get KURN Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

-81

Gross Margin:

60

CFO / Debt ratio:

hidden

Current ratio:

2.461

Debt / Equity ratio:

0.027

ROE:

-21

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

KURN.SW analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for KURN.SW to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Kuros Biosciences AG competitors

AB

ABBV

Abbvie Inc

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Ill...

Discover

AM

AMGN

Amgen Inc

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company...

Discover

VR

VRTX

Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs fo...

Discover

Kuros Biosciences AG dividends

KURN.SW dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About KURN.SW stock

About the company Kuros Biosciences AG

Market cap $B

0.507

Dividend yield

Shares outstanding

36.544156 B

Kuros Biosciences Ltd. develops spinal fusion biologics that ease the burden of back pain. The company is headquartered in Schlieren, Zuerich. The company went IPO on 2002-10-29. Immunodrugs are therapeutic vaccines intended for treating and preventing common chronic diseases, such as hypertension, nicotine addiction, allergic diseases, asthma, malignant melanoma and Alzheimer's disease. They are designed to instruct the patient's immune system to produce desired therapeutic antibody or T cell responses that modulate chronic disease processes. The firm has built a pipeline of different Immunodrug candidates, of which five are in clinical development. Its Immunodrug candidates are developed both in-house and together with Novartis, Pfizer and Pfizer Animal Health, among others. The firm has two subsidiaries: a wholly-owned Proteome Therapeutics GmbH and minority owned BioSupport AG.

KURN.SW profile

  • Ticker

    KURN.SW

  • Country

    Switzerland

  • Exchange

    XSWX - Six Swiss Exchange

  • Report currency

    CHF - Swiss franc

  • IPO date

    29 October 2002

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

    64

  • City

    Schlieren

  • Address

    Wagistrasse 25

  • Cusip

    H4769G117